FDA and Harvard Medical School staff discuss the history and use of the agencys Sentinel medical product safety system.
FDA warns ActiveHerb Technology about multiple violations in its manufacture and sale of unapproved and misbranded new drugs.
FDA clears a Misonix 510(k) for Nexus, an ultrasonic surgical platform.
The House Appropriations Committee marks up and passes the fiscal year 2020 Agriculture/FDA appropriations bill that would provide the agency with an ...
Boehringer Ingelheim expresses general support for an FDA final guidance on considerations in demonstrating interchangeability with a reference produc...
FDA releases its latest batch of Warning Letters that includes ActiveHerb Technology and Kingston Pharma.
Federal Register notice: FDA submits to OMB an information collection extension for Guidance for Industry on Establishing That a Tobacco Product Was C...
FDA accepts for review a Celgene and Acceleron BLA for luspatercept for treating certain patients with very low to intermediate-risk myelodysplastic s...